We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
- Trasylol Lawsuits and Patient Safety
- Trasylol Information News Video | Trasylol Class Action Lawsuit For Heart Surgery | Kidney Failure Stroke
- How To Find Out If Trasylol Was Used During Heart Surgery
- Trasylol Information News Video | Trasylol Heart Medication Class Action Lawsuit Attorney Lawyer
- Trasylol Information News Video | Trasylol Kidney Problems Attorneys| Renal Failure Lawsuits
- Lessons From Trasylol Side Effects And Safety Studies
- Trasylol News Video | Trasylol Heart Surgery Attorney CABG Lawyer | Kidney Failure Problems
Trasylol Heart Surgery Risks
There are estimates that at least 10,000 patients may unnecessarily have suffered kidney damage due to use of aprotinin during heart surgery. Many patients may have been injected with Trasylol to reduce blood loss during coronary artery bypass (CABG) surgery.
The Food and Drug Administration approved Aprotinin in 1993, a drug marketed by Bayer as Trasylol. Sales of Trasylol over the past several years have escalated to more than $600 million.
Trasylol Attorneys
Patients undergoing heart surgery are largely unaware if Trasylol was used during their heart surgery. The decision to use aprotinin (Trasylol) was made by a patient's treating doctor.
We realize that most patients have had successful heart surgeries and are concerned that nothing negative happens to their doctors. We are here to make sure that if you have suffered Trasylol kidney damage, stroke or heart failure we will work to hold the responsible drug company accountable.
Trasylol Linked to Kidney Failure, Stroke and Heart Attacks
A recent study, published by the New England Journal of Medicine (NEJM) (2006) reported a connection between Trasylol and increased risk of renal (kidney) failure, myocardial infarction, heart failure or stroke in patients who have had heart surgery.
What is Aprotinin Injection?
Aprotinin (Trasylol) affects the way in which blood clots. Trasylol is injected into patients who are undergoing open heart surgery. Excessive bleeding, during and after heart surgery, is a serious complication. Such bleeding exposes patients to multiple risks. Trasylol is primarily used during repeat coronary artery bypass surgery to reduce the amount of bleeding. The amount of blood transfusion required is reduced by using clotting medications including Trasylol.
Alternative Drugs Available - Safer and Less Expensive
The NEJM study concluded that 2 other generic drugs are available that are safer and less expensive than Trasylol.
- The generic Amicar cost per dose s $11
- The generic Cyklokapron cost per dose is $44
- Trasylol cost per dose is $1300.
Neither of the generic drugs was associated with increased risk of kidney failure, heart attack or stroke.
Trasylol Kidney Failure and Heart Failure Warnings
The federal Food and Drug Administrations (FDA) Cardiovascular and Renal Drug Advisory Committee met on September 21, 2006 to review recent data regarding the safety of aprotinin. On September 29, 2006, the FDA issued a public health advisory stating that it had learned Bayer failed to disclose a study that Bayer had conducted involving 67,000 patients undergoing heart surgery. Preliminary analysis of the Bayer study suggested that Trasylol use was linked with risk for congestive heart failure, kidney disease, stoke and death. Bayer did not disclose the study during the September 21, 2006 Advisory Committee meeting.
If you or a loved one has had open heart surgery and then experienced Trasylol kidney damage, heart failure or stroke, you may be able entitled to money damages. Trasylol attorneys can help evaluate your claim.
Trasylol lawsuits continue to be filed around the United States on behalf of patients suffering from kidney failure and stroke problems and families who are pursuing wrongful death claims on behalf of loved ones who died following heart surgery. The Supreme Court is set to hear the case of Wyeth v. Levine later this year. […]
Patients and families across the country are becoming aware of the devastating effects of Trasylol. Stroke, kidney failure, heart attack and death in patients are being reported in increasing numbers as hospital records are checked and it is discovered that Trasylol was used during open heart surgery.
On February 8, 2006, the FDA issued a public […]
One of the biggest questions people have when they or a family member have suffered side effects such as kidney failure, stroke or a heart attack following open heart surgery is how to find out whether or not Trasylol was used during the surgery. Patients who underwent bypass surgery most often do not know what […]
Bayer is reviewing the results of the Canadian study of their Trasylol heart medication drug. Trasylol problems including kidney failure, stroke and death have affected thousands of patients across the United States. The Canadian study (referred to as the “BART” study) was a randomized clinical trial involving patients who underwent one of the following procedures: […]
In November 2007, Bayer withdrew its heart surgery drug Trasylol from the marketplace. A study based on observations at sixty nine cardiac centers was published that showed Trasylol kidney failure along with other serious side effects such as heart failure and stroke. The observational study raised significant questions regarding the safety of Bayer’s drug.
The study […]
